80 results
Page 3 of 4
8-K
EX-99.1
ptw oawwwa
10 May 21
VBI Vaccines Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
1795ph xe9pxq
28 Apr 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
g6yu628el
21 Apr 21
Regulation FD Disclosure
8:00am
8-K
EX-99.2
v6if tb1u01h
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.1
zgip73w
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.1
anxkgp
2 Mar 21
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
8:00am
8-K
EX-99.1
ufpmhp vs33jnkdgxass
2 Feb 21
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
8:21am
8-K
EX-99.1
1ot09lyv6 4zzya7
21 Jan 21
VBI Vaccines Announces Progress of Coronavirus Vaccine Program
9:25am
8-K
EX-99.1
d61118ok7r3drimbd
18 Nov 20
VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B
8:55am
8-K
EX-99.1
smmod2 rnl
2 Nov 20
VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
11:31am
8-K
2e8e7i95
5 Aug 20
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
9:00am
8-K
EX-99.1
5pe87tq1jjw5i j0it
5 Aug 20
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
9:00am
S-3ASR
k4w32ii ynq
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.1
7dd3trj6kq6v9
17 Jun 20
VBI Vaccines to Present at Upcoming Investor Conferences
8:54am